These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4917065)

  • 1. [Antigens of Vibrio cholera (review of the literature)].
    Kereselidze TS
    Zh Mikrobiol Epidemiol Immunobiol; 1970 May; 47(5):60-5. PubMed ID: 4917065
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of cholera cerisis inhibiting factor. 1. Isolation and specificity of the active substances from the small intestine of rabbits immunized with inactivated Vibrio cholerae].
    Morimoto T; Yamamoto M; Maruyama S; Turumizu T; Matsui S
    Yakugaku Zasshi; 1971 Dec; 91(12):1354-61. PubMed ID: 5004220
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to cholera: relation of fraction II of type 2 cholera toxin to vibriocidal antibody.
    Kaur J; Burrows W
    J Bacteriol; 1969 May; 98(2):467-74. PubMed ID: 4977478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the cholera toxin and antitoxin.
    Ungar J; Stanić M; Varallyay SJ; Chariatte N
    Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and characterization o;f a hemolysin produced by Vibrio parahaemolyticus.
    Zen-Yoji H; Hitokoto H; Morozumi S; Le Clair RA
    J Infect Dis; 1971 Jun; 123(6):665-7. PubMed ID: 4999909
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative studies on the protective value of different antigenic preparations from cholera vibrios.
    Sanyal SC; Narayanaswami A; Mukerjee S
    Indian J Med Res; 1969 Sep; 57(9):1621-8. PubMed ID: 5369787
    [No Abstract]   [Full Text] [Related]  

  • 7. Separation of protective bacterial substances against experimental vibrio infection.
    Yoshioka M; Takahashi K; Hirano T; Kazuno Y; Takeuchi S; Akiba Y; Ghoda A; Suzuki T; Suzuki Y
    J Infect Dis; 1970 May; 121():Suppl 121:45+. PubMed ID: 5421428
    [No Abstract]   [Full Text] [Related]  

  • 8. Attempt to characterize choleragenic fraction and the skin permeability factor from vibrio culture filtrates as separate indentity.
    Chatterjee PK; Rao SS; Dutta NK
    Indian J Med Res; 1972 Nov; 60(11):1568-74. PubMed ID: 4654627
    [No Abstract]   [Full Text] [Related]  

  • 9. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    J Infect Dis; 1970 May; 121(5):505-13. PubMed ID: 4986889
    [No Abstract]   [Full Text] [Related]  

  • 10. Procholeragenoid: an aggregated intermediate in the formation of choleragenoid.
    Finkelstein RA; Fujita K; LoSpalluto JJ
    J Immunol; 1971 Oct; 107(4):1043-51. PubMed ID: 4999257
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization and purification of cholera toxin.
    Heckly RJ; Wolochow H
    J Infect Dis; 1970 May; 121():Suppl 121:80+. PubMed ID: 5421431
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of cholerogen and isolated cellular components of V. cholerae].
    Zykin LF; Lobanov VN; Sageeva OF; Petrova LS
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):36-43. PubMed ID: 5519104
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of the exotoxin from cholera vibrio El Tor].
    Korovkina GV; Kozarenko TD; Pugacheva NN; Urbanovich LIa; Karetnikova ES
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Nov; 50(11):50-4. PubMed ID: 4593077
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on K antigen of Vibrio parahaemolyticus. l. Immunochemical specificity of 02:K 3 and 02:K 28 antigens and their carhydrate constituents].
    Kudo Y
    Nihon Saikingaku Zasshi; 1969 Apr; 24(3):174-82. PubMed ID: 4979864
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic analysis of vibrio culture filtrate and vaccine El Tor vibrio.
    Sanyal SC; Narayanaswami A; Mukerjee S
    J Hyg (Lond); 1969 Sep; 67(3):539-44. PubMed ID: 4980363
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of vibriocidal antibodies with regard to immunity to cholera.
    Gangarosa EJ; DeWitt WE; Feeley JC; Adams MR
    J Infect Dis; 1970 May; 121():Suppl 121:36+. PubMed ID: 4912071
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.
    Neoh SH; Rowley D
    J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023
    [No Abstract]   [Full Text] [Related]  

  • 18. Subunit structure of cholera toxin.
    Lönnroth I; Holmgren J
    J Gen Microbiol; 1973 Jun; 76(2):417-27. PubMed ID: 4198716
    [No Abstract]   [Full Text] [Related]  

  • 19. The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests.
    Mosley WH; Woodward WE; Aziz KM; Rahman AS; Chowdhury AK; Ahmed A; Feeley JC
    J Infect Dis; 1970 May; 121():Suppl 121:1-9. PubMed ID: 4912069
    [No Abstract]   [Full Text] [Related]  

  • 20. [Utilization of mice macrophages to estimate the post-vaccinal anticholeraic immunity].
    Dodin A; Wiart J; Gallut J
    C R Acad Hebd Seances Acad Sci D; 1971 Feb; 272(8):1189-91. PubMed ID: 4995281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.